Author(s):
Asmi Manoj Bhavsar, Savita Bapu Bhil, Javesh K. Patil, S.P. Pawar.
Email(s):
asmibhavsar234@gmail.com
DOI:
10.52711/2231-5659.2026.00013 
Address:
Asmi Manoj Bhavsar, Savita Bapu Bhil, Javesh K. Patil, S.P. Pawar.
Department of Pharmaceutics, P.S.G.V.P. Mandal’s College of Pharmacy, Shahada, 425409, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 1,
Year - 2026
ABSTRACT:
Cancer comprises a group of approximately 100 diseases that have afflicted humanity since ancient times. In 2012 alone, an estimated 8.2 million people worldwide died from cancer, and this number is projected to rise to 13 million by 2030. Despite advancements in conventional therapeutic approaches, the overall outcomes for cancer patients have not improved significantly. As a result, there is a growing demand for alternative therapies and the development of new, effective anticancer drugs. Plants and their extracts have long been used in traditional medicine to treat various ailments and alleviate physical suffering. Herbal products have been widely employed across different cultures to manage a range of diseases. Several active compounds derived from herbal medicine such as curcumin have demonstrated promising anticancer properties. However, the clinical potential of these phytochemicals is often hindered by their low water solubility and poor bioavailability. This review explores the use of herbal nanocarriers as a novel strategy in cancer therapy, aiming to enhance the delivery and effectiveness of plant-derived anticancer agents.
Cite this article:
Asmi Manoj Bhavsar, Savita Bapu Bhil, Javesh K. Patil, S.P. Pawar. Review on Nanoformulated Phytomedicines for Cancer Therapy. Asian Journal of Research in Pharmaceutical Sciences. 2026; 16(1):79-4. doi: 10.52711/2231-5659.2026.00013
Cite(Electronic):
Asmi Manoj Bhavsar, Savita Bapu Bhil, Javesh K. Patil, S.P. Pawar. Review on Nanoformulated Phytomedicines for Cancer Therapy. Asian Journal of Research in Pharmaceutical Sciences. 2026; 16(1):79-4. doi: 10.52711/2231-5659.2026.00013 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2026-16-1-13
8. REFERENCES:
1. Garima Mathur, Sumitra Nain, Pramod Kumar Sharma. Overview on cancer, Academic Journal of Cancer Research. 2015; 1.
2. Li L., Aggarwal B.B., Shishodia S., Abbruzzese J., Kurzrock R. Nuclear factor- kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer. 2004; 101: 2351–2362.
3. Neag MA, Mocan A, Echeverría J, et al. Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders. Front Pharmacol. 2018; 557.
4. Yang, C.-P.H.; Horwitz, S.B. Taxol®: The First Microtubule Stabilizing Agent. Int. J. Mol. Sci. 2017; 18: 1733.
5. Wu, Y., Antony S., Meitzler J. L., and Doroshow J. H. Molecular mechanisms underlying chronic inflammation‐associated cancers. Cancer Lett. 2014; 345:164–173.
6. Qin Y, He L, Chen Y, Wang W, Zhao X, and Wu M. Quercetin affects leptin and its receptor in human gastric cancer MGC-803 cells and JAK-STAT pathway. Chin J Cell Mol Immunol. 2012; 28(1): 12–6.
7. Alghzzawy Z. M. Elmaghraby T. K. Hagag S. A. Awwad M. H. Effect of vascular disrupting agent (CA4P) and ionizing radiation on tumor growth in rats. J. Basic Environ. Sci. 2019; 6(2): 97–103.
8. Koster DA, Croquette V, Dekker C, Shuman S, Dekker NH. Friction and torque govern the relaxation of DNA supercoils by eukaryotic topoisomerase IB. Nature. 2005; 434: 671–674.
9. Zhao Y., Yang L.F., Ye M., Gu H.H., Cao Y. Induction of apoptosis by epigallocatechin-3-gallate via mitochondrial signal transduction pathway. Prev Med. 2004; 39: 1172–1179.
10. Choi E.-O., Park C., Hwang H.-J., Hong S.H., Kim G.-Y., Cho E.-J., Kim W.-J., and Choi Y.H. Baicalein induces apoptosis via ROS-dependent activation of caspases in human bladder cancer 5637 cells. Int. J. Oncol. 2016; 49: 1009–1018.
11. Martino E, Casamassima G, Castiglione S, Cellupica E, Pantalone S, Papagni F, Rui M, Siciliano AM, Collina S. Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead. Bioorg Med Chem Lett. 2018 Sep 15; 28(17): 2816-2826.
12. Cheng WW, Allen TM (2008) Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab′ fragments and single chain Fv. J Control Release 126(1): 50-58.
13. Koning GA, Kamps JAAM, Scherphof GL. Interference of macrophages with immunotargeting of liposomes. J Liposome Res 2002; 12:107–11.
14. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 1995; 55: 3752–3756.
15. Javesh Patil, Tejasweeni Girase, Sulbha G. Patil, Hemant Suryawanshi and Sunila A. Patil. Conjugated Polymeric Liposomes: A Hybrid Carrier for Contemporary Drug Delivery, in Proceedings of the 26th International Electronic Conference on Synthetic Organic Chemistry. 15–30 November 2022, MDPI: Basel, Switzerland, Chemistry Proceedings, 12 (12), 2022, 1-7.
16. Mrityunjoy Mahato, Sanjukta Patra, Manashjit Gogoi Pages 55-60.
17. Kim TH, Jiang HH, Youn YS, Park CW, Tak KK, Lee S et al. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int J Pharm. 2011; 403:285–291.
18. Tak J., Sabarwal A., Shyanti R.K., Singh R.P. Berberine enhances posttranslational protein stability of p21/cip1 in breast cancer cells via down- regulation of Akt. Mol. Cell. Biochem. 2019; 458: 49–59.
19. Boissenot T, Fattal E, Bordat A, Houvenagel S, Valette J, Chacun H, Gueutin C, Tsapis N (2016) Paclitaxel-loaded PEGylated nanocapsules of perfluorooctyl bromide as theranostic agents. Eur J Pharm Biopharm 108:136–144.
20. Mrityunjoy Mahato, Sanjukta Patra, Manashjit Gogoi Pages 60-63.
21. Hare JI, Lammers T, Ashford MB, Puri S, Storm G, Barry ST. Challenges and strategies in anticancer nanomedicine development: an industry perspective. Adv Drug Deliv Rev. 2017; 108: 25–38.
22. Reason Wilken; Mysore S Veena. Marilee B Wang and Eri S Srivastan, curcumin: A review of anticancer properties and therapeutic activity in head and neck squamous cell carcinoma 2011.